A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium

Last updated: September 2, 2025
Sponsor: Takeda
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cytomegalovirus Infections

Treatment

No Intervention

Clinical Study ID

NCT06677892
TAK-620-4014
  • Ages > 18
  • All Genders

Study Summary

Cytomegalovirus (CMV) is a common virus that infects many people. It can cause serious illness in people with weak immune systems especially in those undergoing transplants. Maribavir is a medicine approved for treating CMV infection in adults after transplant.

The main aim of this study is to check the use of maribavir and learn how safe and effective in treating adults with CMV infection after transplant in Belgium in line with the Belgian reimbursement criteria.

During the study, a participant's data will be collected for 2 years. The study does not have fixed visits to the hospital, but it is recommended collect data from routine visits and contacts.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Participant signed an informed consent form.

  • Aged greater than or equal to (>=) 18 years at the time of consent.

  • Received an HSCT/SOT.

  • Diagnosed with CMV infection/disease any time after the HSCT/SOT date.

  • Starting maribavir for the first time and in line with the Belgian reimbursementcriteria.

Exclusion

Exclusion Criteria:

• Participant treated with maribavir before the start of the study.

Study Design

Total Participants: 75
Treatment Group(s): 1
Primary Treatment: No Intervention
Phase:
Study Start date:
February 24, 2025
Estimated Completion Date:
September 01, 2026

Connect with a study center

  • Hôpital Erasme

    Anderlecht, 1070
    Belgium

    Site Not Available

  • Institut Jules Bordet

    Anderlecht, 1070
    Belgium

    Active - Recruiting

  • Hôpital Erasme

    Anderlecht 2803201, 1070
    Belgium

    Active - Recruiting

  • Institut Jules Bordet

    Anderlecht 2803201, 1070
    Belgium

    Active - Recruiting

  • Cliniques Universitaires Saint-Luc

    Brussels 2800866, 1200
    Belgium

    Active - Recruiting

  • Cliniques Universitaires Saint-Luc

    Bruxelles, 1200
    Belgium

    Site Not Available

  • UZA

    Edegem, 2640
    Belgium

    Site Not Available

  • UZA

    Edegem 2799007, 2640
    Belgium

    Active - Recruiting

  • UZGent

    Gent, 9000
    Belgium

    Site Not Available

  • UZGent

    Ghent 2797656, 9000
    Belgium

    Active - Recruiting

  • UZBrussel

    Jette, 1090
    Belgium

    Site Not Available

  • UZBrussel

    Jette 2794914, 1090
    Belgium

    Active - Recruiting

  • UZLeuven

    Leuven, 3000
    Belgium

    Site Not Available

  • UZLeuven

    Leuven 2792482, 3000
    Belgium

    Active - Recruiting

  • CHU de Liège - site Sart Tilman

    Liège, 4000
    Belgium

    Site Not Available

  • CHU de Liège - site Sart Tilman

    Liège 2792413, 4000
    Belgium

    Active - Recruiting

  • CHU UCL Namur - site Godinne

    Yvoir, 5530
    Belgium

    Site Not Available

  • CHU UCL Namur - site Godinne

    Yvoir 2783385, 5530
    Belgium

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.